ArticleBMJ open2019

Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY).

Sergio Leonardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.